Daejeon, South Korea

Eun-Kyeong Jo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun-Kyeong Jo: Innovator in Interleukin-6 Research

Introduction

Eun-Kyeong Jo is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic agents. Her work focuses on interleukin-6 (IL-6), a cytokine involved in various inflammatory and autoimmune diseases.

Latest Patents

Eun-Kyeong Jo holds a patent for a novel repebody designed to specifically bind to interleukin-6. The patent, titled "Repebody for novel interleukin-6 and use thereof," describes a repebody that inhibits the biological activity of IL-6. This invention includes a polynucleotide encoding the repebody, a vector containing the polynucleotide, and a recombinant microorganism that incorporates the polynucleotide or vector. The patent also outlines methods for producing the repebody and its application in compositions for preventing or treating cancer. The repebody significantly reduces the activity of signal transduction and activator of transcription 3 (STAT3) and the concentration of interleukin-6, making it a promising agent for IL-6-related diseases. Eun-Kyeong Jo has 1 patent to her name.

Career Highlights

Throughout her career, Eun-Kyeong Jo has worked with esteemed institutions such as the Korea Advanced Institute of Science and Technology and the Industry & Academic Cooperation in Chungnam National University. Her research has garnered attention for its potential impact on cancer treatment and other IL-6-related conditions.

Collaborations

Eun-Kyeong Jo has collaborated with notable colleagues, including Hak-Sung Kim and Joong-Jae Lee. These partnerships have contributed to the advancement of her research and the development of innovative solutions in the field.

Conclusion

Eun-Kyeong Jo is a trailblazer in the realm of interleukin-6 research, with her patented innovations paving the way for new therapeutic approaches. Her contributions to science and medicine highlight the importance of continued research in combating diseases related to IL-6.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…